Therapeutic goods regulation
The regulatory framework reflects and upholds the Australian community’s expectations around the safety and quality of therapeutic goods on the market.
Latest alerts
-
Consumers and health professionals should be aware that two unrelated cases of counterfeit injectable botulinum toxin products have been stopped at the Australian border.
-
Stryker is conducting an Urgent Recall of certain serial numbers of the HeartSine Defibrillators.
-
Stryker is conducting an urgent recall of certain lots of the HeartSine Samaritan Public Access Defibrillator Pak (PAD-PAK). Stryker is now attempting to reach the small percentage of customers affected.
Latest articles
-
Summit Pharmacy Pty Ltd issued infringement notices for the alleged unlawful manufacturing of medicinal cannabis products
We have issued 4 infringement notices totalling $75,120 to Queensland based pharmacy Summit Pharmacy Pty Ltd, for the alleged unlawful manufacturing of medicinal cannabis products. -
Your Solution Compounding Pharmacy undertakes to comply with advertising rules for weight-loss medicines
We have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss. -
Enforceable undertaking: Your Solution Compounding Pharmacy
We have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
Latest publications
-
This Cost Recovery Implementation Statement (CRIS) 2025-2026 provides information on how we implement, and cost recover our regulatory activities.
-
Communique from the meeting of the TGACC
-
This report provides information about our regulatory performance for the 2023-24 financial year.